A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NBs / neuroblastomas

[Related PubMed/MEDLINE]
Total Number of Papers: 61
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NBs  (>> Co-occurring Abbreviation)
Long Form:   neuroblastomas
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Glypican-3 expression in malignant small round cell tumors. DSRCTs, EWSs, GPC3
2018 The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII. ---
2018 Vandetanib inhibits cisplatin‑resistant neuroblastoma tumor growth and invasion. IHC, NB
2017 A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors. ECM, PNB
2017 Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification. CNVs, EFS, MNA, NGS
2017 GATA3 is a reliable marker for neuroblastoma in limited samples, including FNA Cell Blocks, core biopsies, and touch imprints. ---
2017 Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival. IDRFs, MNA, NCA, SCA
2016 Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma. ---
2015 Preoperative surgical simulation of laparoscopic adrenalectomy for neuroblastoma using a three-dimensional printed model based on preoperative CT images. CT
10  2015 Prokineticin signaling is required for the maintenance of a de novo population of c-KIT⁺ cells to sustain neuroblastoma progression. ---
11  2015 Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells. PRMT5
12  2015 Retinoic acid-induced CHD5 upregulation and neuronal differentiation of neuroblastoma. 13cRA, CHD5, SY5Y, SY5Y-TrkA
13  2015 The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex. CHD5, GATAD2A, HDAC, IP, MBD, MTA, NuRD, RBBP, TSG
14  2014 Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) inNeuroblastic Tumors; Special Reference to Clinicopathological Correlations withInternational Neuroblastoma Pathology Classification and Outcomes. NTs, SSTR
15  2014 Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics. CFMs, IkappaB
16  2014 The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. ROS
17  2013 GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours. EFS, HR, nGNBs, NTs, OS
18  2013 Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions. tDMRs
19  2013 Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state. ---
20  2013 TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. ---
21  2012 Calreticulin mediates nerve growth factor-induced neuronal differentiation. CRT, ERK, MAPK, NGF
22  2012 Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors. AT/RT, CLDN6, CNS, HBs, MRTs, PNET, SSs
23  2012 Clinical significance of NTRK family gene expression in neuroblastomas. BDNF, NGF, RT-PCR
24  2012 Mechanisms of CHD5 Inactivation in neuroblastomas. ---
25  2012 PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas. EFS, GNs, LD, LI, LNM, UD/PD
26  2012 VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours. GNs, VEGF, VEGFR-3c
27  2011 Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification. SNP
28  2011 Identification of therapy-sensitive and therapy-resistant neuroblastoma subtypes in stages III, IVs and IV. INPC
29  2011 The effect of P75 on Trk receptors in neuroblastomas. ---
30  2010 High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. MNA
31  2010 Neuroblastoma cells can be classified according to glycosphingolipid expression profiles identified by liquid chromatography-tandem mass spectrometry. LC-MS
32  2010 Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis. NT-3, TrkC
33  2008 Rare occurrence of PHOX2b mutations in sporadic neuroblastomas. ---
34  2006 The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. ---
35  2005 Diversity in neuroblastomas and discrimination of the risk to progress. INPC
36  2004 Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas. GRP
37  2004 SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. RCC, TSG
38  2004 TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. ---
39  2003 Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma. ---
40  2003 PPM1D is a potential target for 17q gain in neuroblastoma. ---
41  2002 Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. ---
42  2002 No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3. LOH
43  2001 GD2 synthase: a new molecular marker for detecting neuroblastoma. BMs, HIST, IF, PBL, RT-PCR
44  2001 Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. EFS, FH, GN, GNBi, GNBn, International Classification, MKI, NTs, UH
45  2001 Neuroblastoma cells provoke Schwann cell proliferation in vitro. BrdU, NF, SCs, TUNEL
46  2000 Deletion mapping of 14q32 in human neuroblastoma defines an 1,100-kb region of common allelic loss. BAC, LOH, SRO
47  2000 Risk of unfavorable character among neuroblastomas detected through mass screening. The Japanese Infantile Neuroblastoma Cooperative Study. ---
48  2000 The p73 gene is less involved in the development but involved in the progression of neuroblastoma. FISH, LOH, RT-PCR
49  1999 [Histopathologic differentiation of tumors derived from neuroblastic cells in children depending on age]. ---
50  1998 Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome. 1p-LOH, CI, FISH, OS
51  1998 Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptase-polymerase chain reaction of chromogranin mRNA. CgA, ESs, PNETs, RT-PCR, SgII
52  1998 Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening. ---
53  1998 Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique (SFOP). CAdO, CE, EFS, LN, NMA, OS, RR, SFOP
54  1997 Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells. HA
55  1995 Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. beta 2m
56  1995 Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. ---
57  1995 Schwann cells in neuroblastoma. ---
58  1994 Pathology of neuroblastic tumors. GNBs, GNs, NTs
59  1992 Differences of L-myc polymorphic patterns of neuroblastoma in patients under 1 year versus older ages: a preliminary report. RFLP
60  1990 In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells. ---
61  1985 Chromosome findings in human neuroblastomas xenografted in nude mice. DMs, HSRs